sGC stimulator has added value in worsening HFrEF patients
This video was recorded during the virtual congress of the American College of Cardiology (ACC) 2020.
Paul Armstrong is a Distinguished University Professor at the University of Alberta, Edmonton, AB, Canada.
This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.
Read our summary of this trial
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: